new and special drug
-
Repatha (Evolocumab) | ASCVD | HongKong DengYue Medicine
-
Nemluvio (Nemolizumab-ilto) – Prurigo Nodularis | HongKong DengYue Medicine
-
Livdelzi (Seladelpar) | Primary Biliary Cholangitis | DengYue Med
-
Yorvipath (Palopegteriparatide) | Hypoparathyroidism | DengYue Medicine
-
Voranigo (vorasidenib) – IDH1/IDH2-Mutant Grade 2 Gliomas
-
Sofdra (Sofpironium) | Primary Axillary Hyperhidrosis | DengYue
-
Ohtuvayre (Ensifentrine) – Chronic Obstructive Pulmonary Disease
-
Iqirvo (Elafibranor) | Primary Biliary Cholangitis | DengYue Medicine
-
Xolremdi (Mavorixafor) – WHIM | HongKong DengYue Medicine
-
Ojemda (Tovorafenib) – Pediatric Low-Grade Glioma | HongKong DengYue Medicine
-
Anktiva (Nogapendekin alfa inbakicept-pmln) – BCG-unresponsive NMIBC with CIS
-
Zevtera (Ceftobiprole medocaril sodium) – SAB,ABSSSI,CABP
-
Winrevair (Sotatercept-csrk) – Pulmonary Arterial Hypertension | HongKong DengYue Medicine
-
Tryvio (Aprocitentan) – Hypertension | HongKong DengYue Medicine
-
Resmetirom | Nonalcoholic Steatohepatitis | HongKong DengYue Med
-
Tevimbra | Esophageal Squamous Cell Carcinoma | HongKong DengYue Medicine
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights